Atlas Trials

APR Applied Pharma Research s.a.

16 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch APR Applied Pharma Research s.a.

RecordFirmDate
Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects Under Fed Conditions (NCT06987773)APR Applied Pharma Research s.a.2025-08-20
Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects (NCT06481709)APR Applied Pharma Research s.a.2024-07-30
Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU. (NCT05827536)APR Applied Pharma Research s.a.2023-10-30
Evaluation of Phe Fluctuation in PKU Pts Treated With PKU GOLIKE Versus Standard Amino Acid Protein Substitute. (NCT05487378)APR Applied Pharma Research s.a.2023-06-30
Study on Performance and Safety of Sentinox in the Prevention of Acute Respiratory Infections (ARI) (NCT05499780)APR Applied Pharma Research s.a.2022-11-07
Study to Evaluate the Effect on Nitrogen Retention of Two Different Posology Schemes of PKU GOLIKE PLUS 3-16 and Free AAs in Patients With Phenylketonuria (NCT05229549)APR Applied Pharma Research s.a.2022-05-06
Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19 (NCT05137795)APR Applied Pharma Research s.a.2021-12-15
Study on the Performance and Safety of Sentinox in COVID-19 Patients (NCT04909996)APR Applied Pharma Research s.a.2021-05-20
Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19 (NCT04360096)APR Applied Pharma Research s.a.2021-02-15
Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure (NCT04311697)APR Applied Pharma Research s.a.2020-05-15

Track APR Applied Pharma Research s.a. automatically

Every clearance here is in the API, with alerts when new ones post.